PRIME, PRIME 2 Data Show 12-, 24-Week Improvements in Patien

The LIBERTY-PN PRIME and PRIME2 trials investigated itch response to dupilumab among patients who have prurigo nodularis.

Related Keywords

, Worst Itch Numeric Rating Scale , Investigator Global Assessment , Dermatology Life Quality Index , Prurigo Nodularis , Dupilumab , Wi Nrs , Iga Pn S ,